Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0GJ7B
|
||||
| Former ID |
DNC011100
|
||||
| Drug Name |
NELOTANSERIN
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Sleep disorders [ICD9: 307.4, 327, 780.5; ICD10:F51, G47] | Discontinued in Phase 2 | [548083] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H15BrF2N4O2
|
||||
| Canonical SMILES |
CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)<br />OC
|
||||
| InChI |
1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)
|
||||
| InChIKey |
COSPVUFTLGQDQL-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 839713-36-9
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Modulator | ||
| PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.